XML 70 R46.htm IDEA: XBRL DOCUMENT
v3.25.2

Financial Instruments and Financial Risk Management (Tables) | 12 Months Ended
--- | ---
Mar. 31, 2025
Financial Instruments and Financial Risk Management [Abstract] |
Schedule of Carrying Value of the Financial Instruments | The table below presents the carrying value of the Company’s financial instruments:
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Investment in Psyence Labs Ltd |  |  | - |  |  |  | 745,000 |  |  |  | - |  |  |  | 745,000 |
Derivative warrant liabilities – public warrants |  |  | 200,096 |  |  |  | - |  |  |  | - |  |  |  | 200,096 |
Balance, March 31, 2025 |  |  | 200,096 |  |  |  | 745,000 |  |  |  | - |  |  |  | 945,096 |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Derivative warrant liabilities – private warrants |  |  | - |  |  |  | 26,608 |  |  |  | - |  |  |  | 26,608 |
Derivative warrant liabilities – public warrants |  |  | 875,000 |  |  |  | - |  |  |  | - |  |  |  | 875,000 |
Convertible notes |  |  | - |  |  |  | - |  |  |  | 7,657,397 |  |  |  | 7,657,397 |
NCAC Sponsor promissory note |  |  | - |  |  |  | - |  |  |  | 1,474,256 |  |  |  | 1,474,256 |
PGI promissory note |  |  | - |  |  |  | - |  |  |  | 1,316,236 |  |  |  | 1,316,236 |
Balance, March 31, 2024 |  |  | 875,000 |  |  |  | 26,608 |  |  |  | 10,447,889 |  |  |  | 11,349,497 |
Schedule of Maturity of the Contractual Obligations | The following table set forth the maturity of the contractual obligations as at March 31, 2025 and after
|  | Carrying Amount |  |  | Contractual Cash Flows |  |  | Less than 1 year |  |  | Between 1 and 3 years |
Accounts payable & accrued liabilities |  |  | 394,270 |  |  |  | 394,270 |  |  |  | 394,270 |  |  |  | - |
Total contractual obligations |  |  | 394,270 |  |  |  | 394,270 |  |  |  | 394,270 |  |  |  | - |

X
- Definition The disclosure of detailed information about financial instruments. [Refer: Classes of financial instruments [domain]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 31 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_31&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 7 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_7&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35K -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35K&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the fair value of financial instruments. [Refer: Classes of financial instruments [domain]; At fair value [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 10 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_10_e&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfFinancialInstrumentsAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration